Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Demographic and laboratory data of KTR with low vs. normal serum Mg2+ levels. Variable | Serum Magnesium Level | p | Low (≤1.7 mg/dL) (N = 248) | Normal (≥1.8 mg/dL) (N = 241): 25 OH vitamin D (ng/mL), median (IQR) (N = 465) | 25 (18 to 33) | 25 (18 to 33) | 0.958
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
We conducted a retrospective cross-sectional study in 489 outpatient KTR.
Source: Abstract.
A total of 523 patients were initially considered; 34 met the exclusion criteria, leaving 489 included in the final analysis ().
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Prevalence, Risk Factors and Potential Protective Strategies for Hypomagnesemia in Kidney Transplant Recipients
Cross-sectional study · International Journal of Molecular Sciences · 2025
Original publication title
Prevalence, Risk Factors and Potential Protective Strategies for Hypomagnesemia in Kidney Transplant Recipients
© 2025 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Hypomagnesemia is the most common electrolyte disorder in kidney transplant recipients (KTR), yet its causes remain unclear. Few studies have explored its underlying factors. This study aimed to assess its prevalence and identify risk factors in KTR. We conducted a retrospective cross-sectional study in 489 outpatient KTR. Demographic, clinical, and laboratory data were collected. Univariate and multivariate logistic regression analyses were used to identify factors associated with hypomagnesemia (≤1.7 mg/dL). Hypomagnesemia was present in 50.7% of patients. Multivariate analysis identified tacrolimus [OR 2.91 (1.62 to 5.22)], thiazides [OR 2.23 (1.21 to 4.08)], cinacalcet [OR 2.31 (1.29 to 4.13)], serum phosphate < 3.7 mg/dL [1.99 (1.29 to 3.05)], serum calcium ≤ 10 mg/dL [1.99 (1.29 to 3.05)] and diabetes [1.94 (1.22 to 3.08)] as risk factors.
Protective factors included SGLT2 inhibitors (SGLT2i) [OR 0.17 (0.10 to 0.27)] and mTOR inhibitors (mTORi) [OR 0.62 (0.38 to 0.98)]. Among hypomagnesemic patients, those receiving Mg2+ supplements had lower Mg2+ levels [1.54 (0.15) vs. 1.59 (0.13) mg/dL, p = 0.005] and higher fractional Mg2+ excretion [8.28 (4.48)% vs. 7.36 (4.19)%, p = 0.05]. Hypomagnesemia is highly prevalent in KTR. Tacrolimus, thiazides, and cinacalcet are key risk factors and, in some patients, risks and benefits of continuing these medications should be carefully weighed.
In refractory cases, SGLT2i or mTORi may offer benefit.
Authors’ abstract
Hypomagnesemia is the most common electrolyte disorder in kidney transplant recipients (KTR), yet its causes remain unclear. Few studies have explored its underlying factors. This study aimed to assess its prevalence and identify risk factors in KTR. We conducted a retrospective cross-sectional study in 489 outpatient KTR. Demographic, clinical, and laboratory data were collected. Univariate and multivariate logistic regression analyses were used to identify factors associated with hypomagnesemia (≤1.7 mg/dL). Hypomagnesemia was present in 50.7% of patients. Multivariate analysis identified tacrolimus [OR 2.91 (1.62 to 5.22)], thiazides [OR 2.23 (1.21 to 4.08)], cinacalcet [OR 2.31 (1.29 to 4.13)], serum phosphate < 3.7 mg/dL [1.99 (1.29 to 3.05)], serum calcium ≤ 10 mg/dL [1.99 (1.29 to 3.05)] and diabetes [1.94 (1.22 to 3.08)] as risk factors.
Protective factors included SGLT2 inhibitors (SGLT2i) [OR 0.17 (0.10 to 0.27)] and mTOR inhibitors (mTORi) [OR 0.62 (0.38 to 0.98)]. Among hypomagnesemic patients, those receiving Mg2+ supplements had lower Mg2+ levels [1.54 (0.15) vs. 1.59 (0.13) mg/dL, p = 0.005] and higher fractional Mg2+ excretion [8.28 (4.48)% vs. 7.36 (4.19)%, p = 0.05]. Hypomagnesemia is highly prevalent in KTR. Tacrolimus, thiazides, and cinacalcet are key risk factors and, in some patients, risks and benefits of continuing these medications should be carefully weighed.
In refractory cases, SGLT2i or mTORi may offer benefit.
Publication and source details
Original title: Prevalence, Risk Factors and Potential Protective Strategies for Hypomagnesemia in Kidney Transplant Recipients
Cristina Riaza Ortiz; Carlos Fernández Fernández; Marina Pujol Pujol; María Muñiz Rincón; Arianne Sofía Aiffil Meneses; Isabel María Pérez Flores; Natividad Calvo Romero; María Ángeles Moreno de la Higuera; Beatriz Rodríguez Cubillo; Raquel Ramos Corral; Ana Isabel Sánchez Fructuoso
International Journal of Molecular Sciences · 2025
* Correspondence: cristina.riaza@salud.madrid.org; Tel.: +34-628402196© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T04:07:37.990987+00:00
DOI: 10.3390/ijms26136528 · PMC12250061